ArticleBMJ open respiratory research2026
Clinical, imaging, bronchoscopic characteristics and pulmonary function features in patients with endobronchial tuberculosis: a single-centre cross-sectional study.
Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesEndobronchial tuberculosis (EBTB) is a common manifestation of tuberculosis (TB) that may cause airway obstruction if not promptly diagnosed and treated. This study described clinical, imaging, bronchoscopic characteristics and pulmonary function in patients with EBTB.
designA single-centre cross-sectional study.
settingThe study was conducted at the National Lung Hospital, a tertiary hospital specialised in TB and lung diseases in Vietnam from May 2023 to May 2024.
participantsWe consecutively enrolled 91 patients aged ≥16 years with bacteriologically confirmed EBTB, defined by positive OUTCOME MEASURES: The outcome of our study was the presence of central airway obstruction (CAO), defined as ≥50% narrowing of the trachea, mainstem bronchi, bronchus intermedius, lobar and segmental bronchi visually estimated on bronchoscopy and supported by HRCT findings.
resultsMedian age was 37 years (IQR: 27-54), 64.8% female; 31.9% were post-TB treatment cases and 68.1% newly diagnosed. Overall, 65.9% of patients had ventilatory defects, most commonly the restrictive pattern (66.7%). Lesions were more frequent in the left airway than right (64.8% vs 31.9%, p<0.001). CAO was found in 71.4% of patients, more common in post-TB cases (86.2% vs 64.5%). Multivariate logistic regression analyses showed that three variables were independently associated with the risk of CAO on bronchoscopy, including shorter duration from symptom onset to hospitalisation (<8 weeks) (adjusted OR (aOR) = 3.93, 95% CI 1.18 to 13.03), dyspnoea (aOR = 3.85, 95% CI 1.27 to 11.68) and forced expiratory volume in one second (FEV
conclusionVentilatory defects and CAO were common among patients with EBTB. A high level of suspicion should be applied to patients presenting with dyspnoea, shorter duration from symptom onset to hospitalisation (<8 weeks) and reduced FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.